Literature DB >> 7617786

A clinician's guide to utility measurement.

D A Redelmeier1, A S Detsky.   

Abstract

The approach described in this article is designed for clinicians who are striving to read utility analyses and understand patients' quality of life. We have introduced six questions to illuminate the complex issues underlying utility measurement and acknowledge the challenges encountered in conducting such research. Although not strict guidelines, the six questions provide a structured approach for recognizing high-quality articles and a swift method for discarding low-quality articles. We recognize that many studies seem poor when judged by these criteria, including some of our own. Yet we encourage clinicians, who are otherwise busy, to be selective in identifying utility analysis that merit attention. Without a structured approach, the temptation is to dismiss all articles as worthless and read nothing. The listed criteria, we hope, will help readers appreciate the merits of utility analyses and the role of patients' quality of life in decision analysis.

Entities:  

Mesh:

Year:  1995        PMID: 7617786

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  15 in total

1.  The reproducibility of ophthalmic utility values.

Authors:  G C Brown; M M Brown; S Sharma; G Beauchamp; H Hollands
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes.

Authors:  M M Brown; G C Brown; S Sharma; A F Smith; J Landy
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  Quality of life and relative importance: a comparison of time trade-off and conjoint analysis methods in patients with age-related macular degeneration.

Authors:  P A Aspinall; A R Hill; B Dhillon; A M Armbrecht; P Nelson; C Lumsden; E Farini-Hudson; R Brice; A Vickers; P Buchholz
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

4.  Comment on the value of vision by Knauer et al..

Authors:  George L Spaeth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-17       Impact factor: 3.117

5.  Quality of life and systemic comorbidities in patients with ophthalmic disease.

Authors:  Melissa M Brown; Gary C Brown; Sanjay Sharma; Hussein Hollands; Jennifer Landy
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

6.  The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.

Authors:  Gary C Brown; Melissa M Brown; Heidi C Brown; Sylvia Kindermann; Sanjay Sharma
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Patient perceptions of quality-of-life associated with bilateral visual loss.

Authors:  G C Brown; M M Brown; S Sharma; H C Brown
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

8.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

9.  Variation in treatment preferences and care goals among older patients with diabetes and their physicians.

Authors:  Marshall H Chin; Melinda L Drum; Lei Jin; Morgan E Shook; Elbert S Huang; David O Meltzer
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

Review 10.  The value of vision.

Authors:  Christine Knauer; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.